Drugs / Lentinan
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00002098 | — | HIV infectious disease | AJI Pharma USA | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00002099 | — | HIV infectious disease | AJI Pharma USA | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lentinan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002099 ↗ |
| Known as | LC 33 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108209 ↗ |
| Route | Intravenous | “intravenous lentinan” NCT00002099 ↗ |